Skip to content

Steps must be taken to prevent bias in sex, gender and race in health data gathered using artificial intelligence, Stanford researchers write.

Steps must be taken to prevent bias in sex, gender and race in health data gathered using artificial intelligence, Stanford researchers write.

Published on

As younger adults are being diagnosed with colon cancer, the U.S. Preventive Services Task Force is recommending screening all adults older than 45.

As younger adults are being diagnosed with colon cancer, the U.S. Preventive Services Task Force is recommending screening all adults older than 45.

Sampling one's own lower nasal passages for COVID-19 virus is as efficient as swabs that sample deep in the nasal cavity, Stanford study finds.

Sampling one's own lower nasal passages for COVID-19 virus is as efficient as swabs that sample deep in the nasal cavity, Stanford study finds.

PSA testing is an important tool to spot prostate cancer, but it remains a bit confusing. Stanford urologist James Brooks clarifies some misconceptions.

PSA testing is an important tool to spot prostate cancer, but it remains a bit confusing. Stanford urologist James Brooks clarifies some misconceptions.

Published on

Radiologist Ali Tahvildari grapples with how to deliver an uncertain diagnosis. When does causing worry conflict with a doctor's pledge to "do no harm?"

Radiologist Ali Tahvildari grapples with how to deliver an uncertain diagnosis. When does causing worry conflict with a doctor's pledge to "do no harm?"

Inspired by his son's illness, Ron Davis and colleagues have discovered a diagnostic test for chronic fatigue syndrome, a notoriously elusive disease.

Inspired by his son's illness, Ron Davis and colleagues have discovered a diagnostic test for chronic fatigue syndrome, a notoriously elusive disease.

By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.

By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.